RonanRx (YC S26), a vertically integrated pharmaceutical company founded by Lloyd, launched on Hacker News to offer personalized GLP-1s and peptides, aiming to connect telehealth, EHR, prescriptions, …
Artificial intelligence has become a mainstream wellness tool in 2026, with users relying on chatbots for personalized nutrition and fitness advice, according to a Guardian report on wellness trends. …
Researchers at Stanford Medicine used artificial intelligence to identify BRP (BRINP2-related peptide), a naturally occurring molecule that reduced food intake and body weight in mice and pigs without…
Technology is increasingly being used to modify human biology and cognition rather than the external world, as seen in AI tools that reduce cognitive effort and GLP-1 drugs that suppress desire. This …
Eli Lilly reported positive interim Phase 1b data for its in vivo PCSK9 base editor VERVE-102, showing single-dose LDL-C reductions of up to 62% sustained for 18 months in patients with heterozygous f…